By Peter.
Medicare beneficiaries face significant cost increases in 2026, particularly for Part B premiums, which rise nearly 10%—the largest percentage hike in four years and second-largest in dollar terms historically. This comes amid broader health insurance pressures, including job-based and ACA plans, exacerbating affordability challenges as food, utilities, and necessities remain elevated. With open enrollment ending December 7, 2025, reviewing options is crucial for the 69 million enrollees (including those with disabilities).
Medicare Part B: Sharpest Rise in Years
Part B covers outpatient care, doctor visits, and preventive services. The standard monthly premium jumps to $202.90 (up $17.90 from $185 in 2025), driven by higher medical/pharmaceutical costs, increased usage, and baby boomer enrollment. The annual deductible rises to $283 (up $26 from $257).
Income-related monthly adjustment amounts (IRMAA) for higher earners (based on 2024 tax returns) push premiums up to $689.90 for individuals over $500,000 ($750,000 married filing jointly). CMS notes the hike would have been $11 higher without cuts to skin substitute payments (saving $10B+ after a 2024 fraud spike from $256M in 2019).
The increase erodes the 2.8% Social Security COLA (adding ~$56/month on average, to $2,071 for retirees), netting ~$38 after Part B deduction—hitting low/middle-income seniors hardest, per experts like Jeanne Lambrew (Century Foundation). About 7M+ spend 10%+ of income on Part B alone; Medicaid’s Medicare Savings Programs help low-income folks, but gaps persist.
Medicare Part D: Modest Shifts After 2025 Overhaul
Prescription drug plans stabilize post-Inflation Reduction Act (IRA) tweaks, which capped out-of-pocket at $2,000 (rising to $2,100 in 2026, inflation-adjusted). The 2025 premium stabilization program (subsidies to insurers) held hikes; for 2026, standalone Part D averages $34/month (down from $38), while MA-PD plans dip to $11 (from $13). Deductible max rises to $615 (from $590). Plans drop modestly (~$50 hikes for some, cuts for others); Elevance exits the market.
IRMAA surcharges for Part D range $14.50–$91 based on income. IRA’s $35 insulin cap and free vaccines continue.
Medicare Advantage (MA): Market Pullback Hits 2M+
Covering 54% of beneficiaries, MA faces retrenchment as costs outpace federal reimbursements (up 4.3% but still ~20% over traditional Medicare). Plans drop 10% to 3,373 (from 5,600+ including specials), affecting ~2M enrollees; CVS/Aetna, Elevance, Humana, UnitedHealthcare scale back in 100+ counties. Vermont loses all MA options (BCBS/United exit).
Average choices fall to 39 plans (from 42); fewer $0-premium/PPO options, skimpier supplements (dental allowances down 10% to $2,107). Max out-of-pocket drops slightly to $9,250 (from $9,350), but premiums for MA-PD rise to $66 (from $60). CMS Administrator Dr. Mehmet Oz: “Millions… will continue to have access to a broad range of affordable coverage options.” Long-term, MA remains attractive despite 2026 dips.
Action Steps for Open Enrollment (Ends Dec. 7)
- Compare plans at Medicare.gov or call 1-800-MEDICARE—focus on networks, supplements, and costs.
- Low-income? Check Medicare Savings Programs for premium help.
- Experts like Rachel Schmidt (Georgetown): “Shop if your plan changes—most will have options.”
These shifts—amid 2.8% COLA—could squeeze fixed incomes; proactive review is key.
#Medicare2026 #PartBPremiumHike #MedicareAdvantageChanges #OpenEnrollment
